Zycubo received breakthrough therapy, fast track, rare paediatric disease and orphan drug designations from the FDA.

A Watertown biotech is suspending drug development and laying off essentially all of its workers in a bid to save cash and ...

Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding, bringing its total raised to $30 million. The round was led by Bessemer ...

Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development ...

The San Diego firm took a step in that direction on Tuesday, when it unveiled what it says will be the world’s largest ...

On the 12th (local time), the ‘JP Morgan Healthcare Conference’ opened in San Francisco, U.S. The biggest topic at this ...

Nvidia and Eli Lilly are teaming up on a $1 billion AI-powered lab to accelerate drug discovery, combining robotics, ...

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract Development and Manufacturing Organisations (CDMOs).

J&J, having already announced several manufacturing investments in North Carolina, has announced another one: a new drug ...

Investors are eyeing a rebound in the U.S. biotech sector in 2026, as more companies ​are expected to go public amid a ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.